legal

Health By Evan Allen — Boston Globe

Prosecutors allege two individuals preyed on those searching for addiction recovery help

Pharmalot By Ed Silverman

Appeals court rules FDA ‘arbitrarily and capriciously’ approved a rare disease drug

Pharmalot By Ed Silverman

As lawsuits mounted, Purdue cultivated conversations with a controversial addiction policy group

Pharmalot By Ed Silverman

Compound pharmacies win court battle over an FDA plan for monitoring shipments

Pharmalot By Ed Silverman

Former Mylan IT exec pleads guilty to insider trading on earnings, drug approvals, and merger

Politics By Nicholas Florko

The FDA has just 3 days to decide how to regulate 6.5 million e-cigarette products. But what if it blows past the deadline?

Pharmalot By Ed Silverman

The Purdue bankruptcy plan was approved. Will it get derailed by appeals?

The Readout LOUD By Damian Garde, Meg Tirrell and Adam Feuerstein

Listen: Elizabeth Holmes on trial, FDA in disarray, & the quest for Covid antivirals

Health By John Seewer and Geoff Mulvihill — Associated Press

Purdue bankruptcy settlement leaves families angry, conflicted

First Opinion By Elsa Pearson

Hospital mergers and acquisitions are a bad deal for patients. Why aren’t they being stopped?

Pharmalot By Ed Silverman

Judge approves Purdue’s controversial bankruptcy plan, paving the way for immunity for Sacklers

Health Tech By Matthew Herper and Rick Berke

STAT+ Conversation: Theranos returns

Health Tech By Hyacinth Empinado

Watch: As Elizabeth Holmes stands trial on fraud charges, catch up on the Theranos saga

Health Tech By Damian Garde, Matthew Herper, Katie Palmer and Casey Ross

What to watch for as the long-awaited Elizabeth Holmes fraud trial unfolds

Health Tech By Damian Garde

4 ways Elizabeth Holmes could win over a jury

First Opinion By Aytan Y. Bellin

My aunt’s ‘Kafkaesque journey’ to get the home care she needs

Health Tech By Casey Ross

Elizabeth Holmes will be on trial. But the evidence will expose a bigger collision between tech culture and health care

Pharmalot By Ed Silverman

David Sackler acknowledges ‘moral responsibility’ to address opioid crisis, but refuses to pay settlement without immunity

First Opinion By Michelle McMurry-Heath

Waiving intellectual property rights would compromise global vaccination efforts

Pharmalot By Ed Silverman

Former Medivation exec charged with insider trading after buying stock ‘within minutes’ of learning of a deal

Pharmalot By Ed Silverman

A federal appeals court throws into question the fate of ‘skinny labels’ — and access to generic drugs

First Opinion By Dick Durbin

With the tobacco settlement, the U.S. missed its moment to fortify public health. We can’t make that mistake with the opioid settlement

Exclusive By Olivia Goldhill

Athira cited altered studies in $15 million NIH grant application, creating legal risk

Pharmalot By Ed Silverman

‘Deeply disappointed’: FTC pulls pay-to-delay case after losing authority to force drug makers to relinquish profits

Health By Andrew Joseph

States could get billions from opioid lawsuits. They have to decide how to spend it